title: Complete regression of a non-small cell lung cancer choroidal metastasis with intravitreal bevacizumab.
authors.affiliation: Department of Medical Oncology, S. Andrea Hospital, La Sapienza University, Rome, Italy. dantonio.chiara@gmail.com
authors.forename: Chiara
authors.initials: C
authors.lastname: D'Antonio
authors.forename: Antonella
authors.initials: A
authors.lastname: Viterbo
authors.forename: Adriana
authors.initials: A
authors.lastname: Romiti
authors.forename: Maurizio Maurizi
authors.initials: MM
authors.lastname: Enrici
authors.forename: Salvatore
authors.initials: S
authors.lastname: Lauro
authors.forename: Paolo
authors.initials: P
authors.lastname: Marchetti
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D002830:Choroid Neoplasms / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab